Smartphone assisted migraine therapy - SMARTGEM

Charité Campus Charité Mitte0 个研究点目标入组 1,200 人开始时间: 2018年12月17日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•First presentation in the headache outpatient department of the Charité Universitätsmedizn Berlin, Universitätsmedizin Rostock or Universitätsklinik Halle
•- Diagnosis of episodic migraine with at least 5 migraine days / month or chronic migraine with or without aura according to the IHCD-3 criteria
•- onset of migraine before the age of 50 and lasting for at least a year
•- Own an Android or iOS enabled smartphone with mobile internet access and basic understanding of apps
•- Ability and readiness to give a written informed consent
•- Insured with a statutory health insurance
•- The M-sense calendar has been completed with a compliance rate of at least 80% in the last 28 days prior to inclusion
•- The subject documented at least 5 migraine days in the baseline phase with M-sense over a period of 28 days

•Previous use of the M-sense active app more than 14 days
•Diagnosis of another headache disease besides migraine (all secondary headaches and primary headaches of the ICHD-3 group 3 and 4) Tension-type headaches (ICHD-3 group 2) are allowed, provided they do not account for more than 50% of headache days / month
•Previous or current drug or alcohol abuse within one year prior to visit (excessive or compulsory use as determined by the study physician)
•Current use of medication that indicates evidence of abuse or dependency (exception: analgesic or triptan overuse)
•Taking more than 3 doses / month of opioids or barbiturates

发起方

Charité Campus Charité Mitte